CA Patent

CA2443285A1 — Use of (z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis

Assigned to Aventis Pharmaceuticals Inc · Expires 2002-10-17 · 24y expired

What this patent protects

The invention relates to the use of compound of Formula I in treating patients for the symptoms of multiple sclerosis. (I)

USPTO Abstract

The invention relates to the use of compound of Formula I in treating patients for the symptoms of multiple sclerosis. (I)

Drugs covered by this patent

Patent Metadata

Patent number
CA2443285A1
Jurisdiction
CA
Classification
—
Expires
2002-10-17
Drug substance claim
No
Drug product claim
No
Assignee
Aventis Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.